Literature DB >> 22204735

Community transmission of oseltamivir-resistant A(H1N1)pdm09 influenza.

Aeron C Hurt, Kate Hardie, Noelene J Wilson, Yi-Mo Deng, Maggi Osbourn, Nicole Gehrig, Anne Kelso.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 22204735     DOI： 10.1056/NEJMc1111078

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  65 in total

1.  Mapping the pulmonary environment of animals protected from virulent H1N1 influenza infection using the TLR-2 agonist Pam₂Cys.

Authors:  Edin J Mifsud; Amabel C L Tan; Patrick C Reading; David C Jackson
Journal:  Immunol Cell Biol       Date:  2015-08-14       Impact factor: 5.126

2.  MicroRNA-125a and -b inhibit A20 and MAVS to promote inflammation and impair antiviral response in COPD.

Authors:  Alan C-Y Hsu; Kamal Dua; Malcolm R Starkey; Tatt-Jhong Haw; Prema M Nair; Kristy Nichol; Nathan Zammit; Shane T Grey; Katherine J Baines; Paul S Foster; Philip M Hansbro; Peter A Wark
Journal:  JCI Insight       Date:  2017-04-06

3.  Clinical Practice Guidelines by the Infectious Diseases Society of America: 2018 Update on Diagnosis, Treatment, Chemoprophylaxis, and Institutional Outbreak Management of Seasonal Influenzaa.

Authors:  Timothy M Uyeki; Henry H Bernstein; John S Bradley; Janet A Englund; Thomas M File; Alicia M Fry; Stefan Gravenstein; Frederick G Hayden; Scott A Harper; Jon Mark Hirshon; Michael G Ison; B Lynn Johnston; Shandra L Knight; Allison McGeer; Laura E Riley; Cameron R Wolfe; Paul E Alexander; Andrew T Pavia
Journal:  Clin Infect Dis       Date:  2019-03-05       Impact factor: 9.079

4.  The ongoing battle against influenza: Drug-resistant influenza viruses: why fitness matters.

Authors:  Anne Kelso; Aeron C Hurt
Journal:  Nat Med       Date:  2012-10       Impact factor: 53.440

5.  The H275Y neuraminidase mutation of the pandemic A/H1N1 influenza virus lengthens the eclipse phase and reduces viral output of infected cells, potentially compromising fitness in ferrets.

Authors:  Lady Tatiana Pinilla; Benjamin P Holder; Yacine Abed; Guy Boivin; Catherine A A Beauchemin
Journal:  J Virol       Date:  2012-07-25       Impact factor: 5.103

6.  Comparable fitness and transmissibility between oseltamivir-resistant pandemic 2009 and seasonal H1N1 influenza viruses with the H275Y neuraminidase mutation.

Authors:  Diana D Y Wong; Ka-Tim Choy; Renee W Y Chan; Sin Fun Sia; Hsin-Ping Chiu; Peter P H Cheung; Michael C W Chan; J S Malik Peiris; Hui-Ling Yen
Journal:  J Virol       Date:  2012-07-18       Impact factor: 5.103

Review 7.  Antivirals for treatment of influenza: a systematic review and meta-analysis of observational studies.

Authors:  Jonathan Hsu; Nancy Santesso; Reem Mustafa; Jan Brozek; Yao Long Chen; Jessica P Hopkins; Adrienne Cheung; Gayane Hovhannisyan; Liudmila Ivanova; Signe A Flottorp; Ingvil Saeterdal; Arthur D Wong; Jinhui Tian; Timothy M Uyeki; Elie A Akl; Pablo Alonso-Coello; Fiona Smaill; Holger J Schünemann
Journal:  Ann Intern Med       Date:  2012-02-27       Impact factor: 25.391

8.  Epidemiological and genetic characterization of pH1N1 and H3N2 influenza viruses circulated in MENA region during 2009-2017.

Authors:  Hebah A Al Khatib; Asmaa A Al Thani; Imed Gallouzi; Hadi M Yassine
Journal:  BMC Infect Dis       Date:  2019-04-11       Impact factor: 3.090

9.  Data-driven interdisciplinary mathematical modelling quantitatively unveils competition dynamics of co-circulating influenza strains.

Authors:  Bin-Shenq Ho; Kun-Mao Chao
Journal:  J Transl Med       Date:  2017-07-28       Impact factor: 5.531

Review 10.  Detection and management of antiviral resistance for influenza viruses.

Authors:  Guy Boivin
Journal:  Influenza Other Respir Viruses       Date:  2013-11       Impact factor: 4.380
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.